Harnessing AI to Design Antibodies Against Complex Targets in Autoimmune Diseases and Oncology

Biolojic Design's technology is unlocking new possibilities for the capabilities of antibody technology to maximize the full potential of well-studied biological pathways.

Biolojic Design uses proprietary computer-guided techniques to design novel antibodies against complex therapeutic targets.

Using 3D modeling, the company is able to characterize antibody binding sites with a high degree of precision and make amino acid level changes to dramatically improve their functionality and precision.

Biolojic's technology develops new, previously impossible potential for the power and capabilities of antibody technology to unlock the full potential of well-studied biological pathways.

Investing partner / fund: